Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System
source: pixabay.com

Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System

Editor's Note: Chronic conditions and rare diseases don't discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have…

Continue Reading Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System
Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers
source: shutterstock.com

Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers

Carisma Therapeutics, the manufacturer of CT-0508, issued a press release stating that researchers are conducting a combination study using CAR-M cell therapy plus Keytruda (pembrolizumab) in the treatment of overexpressing…

Continue Reading Carisma Therapeutics is Developing CT-0508 to Target HER2 Positive Cancers
ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs
source: unsplash.com

ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs

According to a recent American Society of Clinical Oncology (ASCO) press release, Dr. Jason Westin provided testimony regarding a nationwide shortage of cancer drugs, numbering more than 15 on the…

Continue Reading ASCO Member Testifies Before Senate Committee on Current Nationwide Shortage of Certain Cancer Drugs

Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%

The words ‘vigorous exercise’ usually bring to mind running marathons or playing pickleball. Inside Precision Medicine reports that researchers at a Sydney, Australia University tracked the daily activity of more…

Continue Reading Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%

Beam Therapeutics Announces a First in Human Testing of Gene Editing Medicine for Cancer  

Beam Therapeutics (Beam) has developed a technique called base editing. The treatment is called BEAM 201. The first patient has been dosed according to a recent statement by the company…

Continue Reading Beam Therapeutics Announces a First in Human Testing of Gene Editing Medicine for Cancer  

For Patients Under Consideration for CAR-T Therapy The Cancer Support Community/Gilda’s Club Has A Free Program

No One Should Face Cancer Alone. That is the mission of the non-profit Cancer Support Community (CSC). It offers emotional support and hope via programs designed for cancer patients, cancer…

Continue Reading For Patients Under Consideration for CAR-T Therapy The Cancer Support Community/Gilda’s Club Has A Free Program
New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
source: shutterstock.com

New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval

According to a press release from the US Food and Drug Administration (FDA), on March 24, 2023, the agency issued a new draft guidance titled Clinical Trial Considerations to Support Accelerated…

Continue Reading New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer
source: pixabay.com

Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer

  Researchers have been grappling for years with the STAT5 protein as a tool to fight cancer. STAT5 is critical because it is partly responsible for the development and progression…

Continue Reading Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer
Study of the Week: BPTA Syndrome Research Uncovers Hereditary Disease Mechanism that Could help Prevent Cancer
source: pixabay.com

Study of the Week: BPTA Syndrome Research Uncovers Hereditary Disease Mechanism that Could help Prevent Cancer

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: BPTA Syndrome Research Uncovers Hereditary Disease Mechanism that Could help Prevent Cancer
Cancer Commons Presents a Webinar Recording: You’re Not Alone—Validating the Caregiver Experience
source: pixabay.com

Cancer Commons Presents a Webinar Recording: You’re Not Alone—Validating the Caregiver Experience

The medical term for an “informal caregiver” describes a person who willingly takes the responsibility to help a spouse, family member, friend, or partner. The level of care and responsibility…

Continue Reading Cancer Commons Presents a Webinar Recording: You’re Not Alone—Validating the Caregiver Experience